MindWalk demos ReefIQ drug discovery tool at AMD AI event
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St to open lower as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Nvidia releases AI safety software it says could have stopped Hugging Face hack
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI
July 23, 2026 4:02 PM EDTAt Advancing AI 2026, MindWalk unveils the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct.
AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp. (MindWalk) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct at AMDs Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMDs... More
